These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A new use for existing technology - continuous precipitation for purification of recombination proteins. Warikoo V; Godawat R Biotechnol J; 2015 Aug; 10(8):1101-2. PubMed ID: 25781861 [No Abstract] [Full Text] [Related]
5. Aggregates in monoclonal antibody manufacturing processes. Vázquez-Rey M; Lang DA Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193 [TBL] [Abstract][Full Text] [Related]
6. Process-scale purification from cell culture supernatants: monoclonal antibodies. Ostlund C; Borwell P; Malm B Dev Biol Stand; 1987; 66():367-75. PubMed ID: 3108053 [TBL] [Abstract][Full Text] [Related]
11. Alternative technologies to generate monoclonal antibodies. Stigbrand T; Ahlström KR; Sundström B; Makiya R; Stendahl U Acta Oncol; 1993; 32(7-8):841-4. PubMed ID: 8305234 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturability. Conley GP; Viswanathan M; Hou Y; Rank DL; Lindberg AP; Cramer SM; Ladner RC; Nixon AE; Chen J Biotechnol Bioeng; 2011 Nov; 108(11):2634-44. PubMed ID: 21618474 [TBL] [Abstract][Full Text] [Related]
13. Integration of cell culture with continuous, on-line sterile downstream processing. Grandics P; Szathmary S; Szathmary Z; O'Neill T Ann N Y Acad Sci; 1991 Dec; 646():322-33. PubMed ID: 1809200 [TBL] [Abstract][Full Text] [Related]
14. Spin filter perfusion system for high density cell culture: production of recombinant urinary type plasminogen activator in CHO cells. Avgerinos GC; Drapeau D; Socolow JS; Mao JI; Hsiao K; Broeze RJ Biotechnology (N Y); 1990 Jan; 8(1):54-8. PubMed ID: 1367426 [TBL] [Abstract][Full Text] [Related]
15. Development of a multi-product leached protein A assay for bioprocess samples containing recombinant human monoclonal antibodies. Ren D; Darlucio MR; Chou JH J Immunol Methods; 2011 Mar; 366(1-2):20-7. PubMed ID: 21315722 [TBL] [Abstract][Full Text] [Related]
16. Purification of a plasminogen activator from Streptococcus uberis. Leigh JA FEMS Microbiol Lett; 1994 May; 118(1-2):153-8. PubMed ID: 8013872 [TBL] [Abstract][Full Text] [Related]
18. Real-time monitoring and control of the load phase of a protein A capture step. Rüdt M; Brestrich N; Rolinger L; Hubbuch J Biotechnol Bioeng; 2017 Feb; 114(2):368-373. PubMed ID: 27543789 [TBL] [Abstract][Full Text] [Related]
19. Definition of a well-characterized biotechnology product. Zoon K; Garnick R Dev Biol Stand; 1998; 96():191-7. PubMed ID: 9890531 [No Abstract] [Full Text] [Related]
20. Optimization of a micro-scale, high throughput process development tool and the demonstration of comparable process performance and product quality with biopharmaceutical manufacturing processes. Evans ST; Stewart KD; Afdahl C; Patel R; Newell KJ J Chromatogr A; 2017 Jul; 1506():73-81. PubMed ID: 28551021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]